financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Market Chatter: GSK Nearing Deal to Acquire US Biotech IDRx for Up to $1 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: GSK Nearing Deal to Acquire US Biotech IDRx for Up to $1 Billion
Jan 8, 2025 7:58 AM

10:41 AM EST, 01/08/2025 (MT Newswires) -- GSK (GSK) is in advanced discussions to acquire privately-owned US biotech company IDRx for up to $1 billion, the Financial Times reported Wednesday, citing people close to the talks.

IDRx is developing a treatment for rare gastrointestinal tumors, according to the report.

GSK and IDRx didn't immediately respond to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 33.78, Change: -0.32, Percent Change: -0.92

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
OMV, ADNOC to merge polyolefins businesses and bid $9.4 bln for Nova Chemicals
OMV, ADNOC to merge polyolefins businesses and bid $9.4 bln for Nova Chemicals
Mar 3, 2025
March 3 (Reuters) - Austria's OMV and Abu Dhabi National Oil Company have agreed to merge their polyolefins businesses through a joint venture, which will bid $9.4 billion to acquire Canada's Nova Chemicals from Abu Dhabi's sovereign wealth fund Mubadala, OMV said on Monday. The joint venture, to be named ‍Borouge Group International, will combine Borealis and Borouge, and foresees...
 Exodus Movement Reports Rise in Q4 Preliminary Revenue
Exodus Movement Reports Rise in Q4 Preliminary Revenue
Mar 3, 2025
04:36 PM EST, 03/03/2025 (MT Newswires) -- Exodus Movement ( EXOD ) late Monday reported preliminary revenue of $44.8 million in Q4, up from $18.5 million a year ago. Exodus is a self-custodial cryptocurrency platform. ...
 ADMA Biologics Swings to Q4 Profit, Revenue Increases; Shares Rise After Hours
ADMA Biologics Swings to Q4 Profit, Revenue Increases; Shares Rise After Hours
Mar 3, 2025
04:38 PM EST, 03/03/2025 (MT Newswires) -- ADMA Biologics ( ADMA ) reported Q4 earnings Monday of $0.46 per diluted share, compared with a loss of $0.08 a year earlier. Three analysts polled by FactSet expected $0.15. Revenue in the three months ended Dec. 31 rose to $117.5 million from $73.9 million a year earlier. Three analysts surveyed by FactSet...
 AST SpaceMobile Stock Moves Higher Despite Q4 Earnings Miss
AST SpaceMobile Stock Moves Higher Despite Q4 Earnings Miss
Mar 3, 2025
AST SpaceMobile Inc ( ASTS ) reported fourth-quarter financial results after the market close on Monday. Here’s a rundown of the results. Q4 Earnings: AST SpaceMobile ( ASTS ) reported fourth-quarter sales of $1.92 million. The company reported a fourth-quarter adjusted loss of 18 cents per share, missing analyst estimates for a loss of 17 cents per share, according to Benzinga Pro. AST SpaceMobile (...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved